Overview
- Researchers led by Ying‑Hui Fu have identified familial natural short sleep (FNSS), a rare inherited mutation that lets carriers sleep far less while keeping normal non‑REM sleep and daytime performance.
- Introducing FNSS‑linked mutations into animal models reduced sleep time and produced signs of protection against memory loss and Alzheimer‑like pathology in rodents.
- A large genetic analysis led by Isabelle Austin‑Zimmerman found about 244 common genomic regions that each shift sleep by only about one minute but together change average sleep by roughly 20 minutes and are linked to higher rates of insomnia, fatigue, mood symptoms, ADHD and type 2 diabetes in the general population.
- Experimental sleep‑restriction studies by Hans van Dongen show that two weeks of 4–6 hours per night causes steady cognitive decline even when people report only mild sleepiness, underlining that self‑reports can miss real impairment.
- Pharmaceutical and clinical interest in targeting these sleep genes is growing, but experts stress FNSS is rare, genetics is only part of sleep need, and long‑term safety data are needed before drugs or screenings are used widely.